These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24483112)

  • 1. [Preliminary study of establishing and assessing IBS-D model rats of gan stagnation and Pi deficiency syndrome].
    Zhao YP; Tang XD; Bian ZX; Wang FY; Yang JQ; Su M; Wang W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1507-14. PubMed ID: 24483112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
    Zhao L; Song W; Zhu P; Zhang Y; Bu P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiation Study of Chinese Medical Syndrome Typing for Diarrhea-predominant Irritable Bowel Syndrome Based on Information of Four Chinese Medical Diagnostic Methods and Brain-gut Peptides].
    Wu HM; Xu ZW; Ao HQ; Shi YF; Hu HY; Ji YP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1200-4. PubMed ID: 26677671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Shen warming Pi strengthening method intervened IBS-D rats: an efficacy assessment].
    Su XL; Tang YP; Zhang J; Bai YB; Shi HX; Liu YJ; Chang YJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):197-202. PubMed ID: 24672945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of moxibustion and acupuncture of combined "Biao-Ben" acupoints on intestinal sensitivity and autonomic nervous system function in rats with diarrhea-predominant irritable bowel syndrome.
    Zhou XL; Wang H; Wu S; Li J; Wu F; Lu W; Zhao JW; Li YH
    Zhen Ci Yan Jiu; 2023 Nov; 48(11):1134-1141. PubMed ID: 37984911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR; Luo JY; Shang L; Kong WM
    Chin J Dig Dis; 2006; 7(2):89-96. PubMed ID: 16643336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moxibustion relieves abdominal hypersensitivity and diarrhea by regulating colonic 5-hydroxytryptamine signaling pathway in rats with diarrhea type irritable bowel syndrome].
    Tong L; Wu LB; Li N; Cheng HL; Cai RL; Chu HR
    Zhen Ci Yan Jiu; 2020 Jul; 45(7):535-40. PubMed ID: 32705826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treating irritable bowel syndrome with diarrhea patients by yigan fupi decoction: a randomized controlled trial].
    Chen MX; Chen JX; Xia L; Fu R; Lu Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):656-60. PubMed ID: 25046944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Fagopyrum cymosum (Trev.) Meisn alcohol extract on defecation and isolated colon of diarrhea-IBS rats and its mechanism].
    Liu LN; Yan J; Sun ZG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec; 34(12):1469-75. PubMed ID: 25632748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of irritable bowel syndrome by Chinese medicine and pharmacy: an analysis of data mining on experiences of experts].
    Zhang BH; Gao R; Li ZH; Li BS; Wang FY; Tang XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):757-60. PubMed ID: 23980353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of huoxiang zhengqi extract for regulating the intestinal motility in rat model of diarrhea-predominant irritable bowel syndrome].
    Lu Y; Li D; Tang F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):941-5. PubMed ID: 21866666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Traditional Chinese medicine syndrome distribution and neuroendocrine mechanisms of irritable bowel syndrome: cross-sectional study].
    Hou ZK; Li M; Xie D; Liu FB
    Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1325-1337. PubMed ID: 28879751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
    Bafutto M; Almeida JR; Leite NV; Costa MB; Oliveira EC; Resende-Filho J
    Arq Gastroenterol; 2013; 50(4):304-9. PubMed ID: 24474234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome].
    Zhu J; Luo HS; Chen L; Zhou T
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2713-7. PubMed ID: 20137275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC; Dong L; Wang Y; Wang SH; Cao MB
    Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linderae Radix water extract treats diarrhea-predominant irritable bowel syndrome in rats: a serum metabolomics study].
    Liu T; Wu ML; Deng GY; He Y; He YR; Deng GM; Ouyang LQ
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5356-5364. PubMed ID: 38114125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome.
    Tang SQ; Wang YL; Xie ZY; Zhang Y; Guo Y; Gao KL; Mao TY; Xie CE; Li JX; Gao XY
    J Integr Med; 2021 May; 19(3):274-281. PubMed ID: 33775600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of irritable bowel syndrome rat model by combination of intestinal infection with Trichinella spiralis and acute stress].
    Leng YX; Wei YY; Zhou SP; Duan LP
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2992-6. PubMed ID: 20137711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of changji'an capsule on mRNA expressions of NPY and ACTH contents in brain-gut axis of IBS-D model rats].
    Fang CF; Tang HM; Liao XH; He JL; Li DT; Qiu ZW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jul; 33(7):948-52. PubMed ID: 24063219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.
    Tamaoki S; Yamauchi Y; Nakano Y; Sakano S; Asagarasu A; Sato M
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1315-23. PubMed ID: 17540858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.